Tests

• Science & Technology

DNA testing predicts bowel cancer risk in people with IBD

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

30 January 2025

• Science & Technology

An AI test to help guide bowel cancer treatment

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

27 January 2025

• Science & Technology

World-first urine test for lung cancer picks out 'zombie' cells

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

6 December 2024

• Health & Medicine

New oesophageal cancer screening trial begins testing the capsule sponge

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

28 November 2024

• Science & Technology

New hand-held scanner could transform cancer and arthritis diagnosis

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

15 October 2024

• Science & Technology
• Health & Medicine

Introducing DIY steps to genetic testing could catch more BRCA-linked cancer cases

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

1 October 2024

• Science & Technology

Papcup: Could this at-home HPV test make cervical screening easier?

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

4 September 2024

• Health & Medicine

Symptom triggered testing helps doctors diagnose ovarian cancer early

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

15 August 2024